iRobot receives FDA approval

By Admin
Share
Follow @AbbyPhillips89 iRobot Corp (IRBT), a leader in delivering robotic solutions, announced today that RP-VITA Remote Presence Robot has received 5...

 

iRobot Corp (IRBT), a leader in delivering robotic solutions, announced today that RP-VITA Remote Presence Robot has received 510(k) clearance by the US Food and Drug Administration (FDA) for use in hospitals. iRobot’s RP-VITA is the first autonomous navigation remote presence robot to receive FDA clearance.

Since the announcement was made, IRBT shares increased from $2.21, or 10.5%, to $23.32.

RP-VITA was developed by iRobot and InTouch Health and combines the latest in autonomous navigation and mobility technologies as well as state-of-the-art telemedicine and electronic health record integration.

In a nutshell, the robot will allow doctors to visit hospital patients remotely. They will be able to view and communicate with the patient via a high-tech iPad application.

According to iRobot, the FDA clearance states RP-VITA ‘can be used for active patient monitoring in pre-operative, peri-operative and post-surgical settings, including cardiovascular, neurological, prenatal, psychological and critical care assessments and examinations.’

This is the first robot to be cleared for everyday use in a hospital setting, sparking a new development in the way we access and communicate with medical professionals in the future.

 

 

How do you feel about iRobot’s latest clearance? Join the discussion on Twitter @HealthCareG

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma